Asensus Surgical (NYSEMKT: ASXC)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Asensus Surgical Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Asensus Surgical Company Info
News & Analysis
Asensus Surgical's Senhance Surgical System is being more widely adopted by surgeons.
Earnings results for the third quarter look great, until you peek under the hood.
After Asensus Surgical joined the Russell 2000 index last month, the stock climbed higher but has since fallen back to earth.
An analyst initiated a buy recommendation for the surgical-robot company.
Shares of the robotic surgical-system manufacturer are soaring, but can this company become the next Intuitive Surgical?
One robotic surgery company and one cybersecurity specialist are bound to impress in the long run.
The robotic surgery specialist is helping to enhance the capabilities of surgeons, but its shares may have come too far, too fast.
The Senhance Surgical System's launch isn't progressing nearly as well as investors had hoped.
TRXC earnings call for the period ending June 30, 2019.
TRXC earnings call for the period ending March 31, 2019.
TRXC earnings call for the period ending December 31, 2018.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.